Check-Cap has begun a U.S. pilot study of its C-Scan system, a preparation-free digestible capsule that helps physicians detect colorectal cancer.
Key details to know:
1. The pilot study is enrolling up to 45 subjects who are at average risk for developing polyps and colon cancer.
2. The study is evaluating the usability, safety and subject compliance of the C-Scan system.
3. "The potential addition of a new screening option that is capsule-based and does not require a bowel prep offers the promise of increasing our screening rates. We are looking to the results of this study and the potential for an effective new screening option for the prevention and early detection of colorectal cancer," said Seth A. Gross, MD, gastroenterologist and associate professor of medicine at NYU Langone Health.